Tim Reilly, Author at HotSpot Therapeutics
November 10, 2022
A Turning Point for Immuno-Oncology
Immunotherapy has been the holy grail in the fight against cancer for the last decade. For good reason, we’ve been...
by Tim Reilly
July 13, 2021
Immuno-Oncology: The Comeback Kid
Now 10 years into the golden era of immuno-oncology (I-O) following the first FDA approval of ipilimumab (anti-CTLA4) in 2011…
by Tim Reilly